The incidence and clinical significance of lymph node micrometastases determined by immunohistochemical staining in stage i-lymph node negative endometrial cancer

Histology and Histopathology

Volumn 27, Issue 2, 2012, Pages 181-185

  McCOY, Amy ^a   Finan, Michael A ^a   Boudreaux, F T ^b   Tucker, J Alan ^a   Lazarchick, John J ^b   Donnell, Robert M ^b   Rocconi, Rodney P ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b Mobile Infirmary Medical Center   (United States)

Author keywords

Endometrial cancer; Immunohistochemistry; Lymph nodes; Micrometastases

Indexed keywords

ADENOCARCINOMA; ARTICLE; CANCER GRADING; CANCER STAGING; ENDOMETRIUM TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; LYMPH NODE METASTASIS; METABOLISM; MICROMETASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; TUMOR RECURRENCE;

ADENOCARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM MICROMETASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING;

EID: 84857774542     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bezu C., Coutant C., Ballester M., Feron J.G., Rouzier R., Uzan S. and Daraï E. (2010). Ultrastaging of lymph node in uterine cancers. J. Exp. Clin. Cancer Res. 29, 5.
2. Boronow R.C., Morrow C.P., Creasman W.T., Disaia P.J., Silverberg S.G., Miller A. and Blessing J.A. (1984). Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet. Gynecol. 63, 825-832.
3. Breast Cancer Study Group (1990). Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Internation (Ludwig) Breast Cancer Study Group. Lancet 335, 1565-1568.
4. Cote R.J., Hawes D., Chaiwun B. and Beattie E.J. Jr (1998). Detection of occult metastases in lung carcinomas: progress and implications for lung cancer staging. J. Surg. Oncol. 69, 265-274.
5. Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E. and Heller P.B. (1987) Surgical pathologic spread patterns of endometrial cancer A Gynecologic Oncology Group Study. Cancer 60, 2035-2041.
6. de Mascarel I., Bonichon F., Coindre J.M. and Trojani M. (1992) Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br. J. Cancer. 66, 523-527.
7. Delpech Y., Coutant C., Darai E. and Barranger E. (2008). Sentinel lymph node evaluation in endometrial cancer and the importance of micrometastases. Surg. Oncol. 17, 237-245.
8. Gonzalez Bosquet J., Keeney G.L., Mariani A., Webb M.J. and Cliby W.A. (2003). Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer. Gynecol. Oncol. 91, 518-525.
9. Greenson J.K., Isenhart C.E., Rice R., Mojzisik C., Houchens D. and Martin E.W. Jr (1994). Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 73, 563-569.
10. Izbicki J.R., Hosch S.B., Pichlmeier U., Rehders A., Busch C., Niendorf A., Passlick B., Broelsch C.E. and Pantel K. (1997). Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N. Engl. J. Med. 337, 1188-1194.
11. Jemal A., Siegel R., Ward E., Hao Y., Xu J. and Thun M.J. (2009). Cancer statistics, 2009. CA Cancer J. Clin. 59, 225-249.
12. Kilgore L.C., Partridge E.E., Alvarez R.D., Austin J.M., Shingleton H.M., Noojin F. 3rd and Conner W. (1995). Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol. Oncol. 56, 29-33.
13. Maehara Y., Oshiro T., Endo K., Baba H., Oda S., Ichiyoshi Y., Kohnoe S. and Sugimachi K. (1996) Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 119, 397-402.
14. Morrow C.P., Bundy B.N., Kurman R.J., Creasman W.T., Heller P., Homesley H.D. and Graham J.E. (1991). Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol. Oncol. 40, 55-65.
15. Niikura H., Okamoto S., Yoshinaga K., Nagase S., Takano T., Ito K. and Yaegashi N. (2007). Detection of micrometastases in the sentinel lymph nodes of patients with endometrial cancer. Gynecol. Oncol. 105, 683-686.
16. Pelosi E., Arena V., Baudino B., Bellò M., Giusti M., Gargiulo T., Palladin D. and Bisi G. (2003). Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl. Med. Commun. 24, 971-975.
17. Reich O., Winter R., Pickel H., Tamussino K., Haas J. and Petru E. (1996). Does the size of pelvic lymph nodes predict metastatic involvement in patients with endometrial cancer? Int. J. Gynecol. Cancer 6, 445-447.